SuperworthTreace Medical Concepts EPS TMCI
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$0.93
- Latest quarter, Q2 FY26
- −$0.24
- Fiscal year 2025
- −$0.94
Treace Medical Concepts' earnings per share was −$0.93 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.24.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.94 | n/a |
| FY2024 | −$0.90 | n/a |
| FY2023 | −$0.81 | n/a |
| FY2022 | −$0.77 | n/a |
| FY2021 | −$0.41 | n/a |
| FY2020 | −$0.13 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.24 | n/a | −$0.93 | |
| Q1 FY26 | −$0.28 | n/a | −$0.97 | |
| Q4 FY25 | −$0.15 | n/a | −$0.94 | |
| Q3 FY25 | −$0.26 | n/a | −$0.80 | |
| Q2 FY25 | −$0.28 | n/a | −$0.79 | |
| Q1 FY25 | −$0.25 | n/a | −$0.85 | |
| Q4 FY24 | −$0.01 | n/a | −$0.90 | |
| Q3 FY24 | −$0.25 | n/a | −$0.99 | |
| Q2 FY24 | −$0.34 | n/a | −$1.02 | |
| Q1 FY24 | −$0.30 | n/a | −$0.88 | |
| Q4 FY23 | −$0.10 | n/a | −$0.81 | |
| Q3 FY23 | −$0.28 | n/a | −$0.79 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Treace Medical Concepts' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TMCITreace Medical Concepts | −$0.93 | |
| INFUInfuSystem | $0.41 | +78% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| MOVMovado | $1.80 | +137% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| Peer median | $1.63 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Treace Medical Concepts
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.